Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma

Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma

Abstract Predictive biomarkers of response to immune checkpoint-based therapies (ICI) remain a critically unmet need in the management of advanced renal cell carcinoma (RCC). The complex interplay of the tumour microenvironment (TME) and the circulating immune response has proven to be challenging t...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryam Soleimani, Marisa Thi, Sajjad Janfaza, Gizem Ozcan, Sylwia Mazurek, Guliz Ozgun, Corinne Maurice-Dror, Bernhard Eigl, Kim Chi, Christian Kollmannsberger, Lucia Nappi
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-59337-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-59337-4

Similar Items